|April 23, 2010||Media contact: Margarita Wagerson
Noah’s Neuroblastoma Endowment Research Fund established at U-M
ANN ARBOR, Mich. - Diana Biorkman, mother of the late Noah Biorkman, will present the Universityof Michigan C.S. MottChildren’s Hospital with a check for $75,000 to establish Noah’s Neuroblastoma Endowment Research Fund. The announcement will take place at 10 a.m., April 27, 2010at the children’s hospital courtyard.
The funds were collected from the more than 1.1 million Christmas cards received from around the world from people who were touched by Noah’s story, which attracted national attention. Noah was 6 years old when he died from neuroblastoma, a cancerous tumor that develops from nerve tissue and occurs in infants and children.
“Children from around the country come to Mott for neuroblastoma treatment and this endowment will allow researchers to further their research, increase the chances of saving children like Noah and hopefully one day find a cure,” says Patricia Warner, chief administrative officer for Mott Children's Hospital and Von Voigtlander Women's Hospital.“This generous gift will help us further our research and help other children.”
Noah’s final wish was to celebrate Christmas in early 2009 and in return more than 1 million people sent him and his family holiday cards, gifts and monetary donations that garnered worldwide attention. Those donations and gifts led to the establishment of Noah’s Neuroblastoma Endowment Research Fund.
“We have made great strides in finding cures and therapies for many types of childhood cancers but a lot remains to be done in the fight against neuroblastoma,” says Rajen Mody, M.D., the pediatric oncologist at U-M C.S. Mott Children’s Hospital who cared for Noah. “Research funds and public awareness are greatly needed to continue making strides against childhood cancer and to find a cure.”
For information about Noah’s Endowment Research Fund or to make a gift, visit http://www.giving.umich.edu/give/mott-noah.
U-M C.S. Mott Children’s Hospital and Women’s Hospital is nationally ranked in eight pediatric specialties in the U.S. News Media Group’s 2009 edition of “America’s Best Children’s Hospitals.” A new 1.1 million square feet, $754 million state of the art facility for children and women will provide a new home for cutting-edge specialty services for newborns, children and women such as the pediatric liver transplant program, Level 1 Pediatric Trauma Program, Pediatric and Adolescent Home Ventilator Program, Craniofacial Anomalies Program, high-risk pregnancy services and specialty gynecological services. The new hospital will enhance the inpatient and outpatient services, the world-renowned MichiganCongenitalHeartCenter, the BirthCenterand the Holden Neonatal Intensive Care Unit.